000			01483 a2200445 4500
005			20250513134218.0
264		0	_c19980226
008			199802s 0 0 eng d
022			_a0090-8258
024	7		_a10.1006/gyno.1997.4906 _2doi
040			_aNLM _beng _cNLM
100	1		_aOlson, J K
245	0	0	_aTaxol hypersensitivity: rapid retreatment is safe and cost effective. _h[electronic resource]
260			_bGynecologic oncology _cJan 1998
300			_a25-8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Hypersensitivity _xeconomics
650	0	4	_aFemale
650	0	4	_aHistamine Antagonists _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aMiddle Aged
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
700	1		_aSood, A K
700	1		_aSorosky, J I
700	1		_aAnderson, B
700	1		_aBuller, R E
773	0		_tGynecologic oncology _gvol. 68 _gno. 1 _gp. 25-8
856	4	0	_uhttps://doi.org/10.1006/gyno.1997.4906 _zAvailable from publisher's website
999			_c9423762 _d9423762